Walleye Capital
WVE icon

Walleye Capital’s Wave Life Sciences WVE Stock Holding History

Walleye Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Buy
28,100
+22,000
+361% +$287K ﹤0.01% 3337
2025
Q4 		$104K Sell
6,100
-12,800
-68% -$130K ﹤0.01% 3854
2025
Q3 		$138K Sell
18,900
-300
-2% -$2.43K ﹤0.01% 3542
2025
Q2 		$125K Buy
19,200
+18,600
+3,100% +$123K ﹤0.01% 3663
2025
Q1 		$4.85K Buy
+600
New +$6.56K ﹤0.01% 4106
2019
Q3 		– Sell
-22,600
Closed -$590K – 2313
2019
Q2 		$590K Buy
+22,600
New +$634K 0.06% 433

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Walleye Capital's WVE Position: Q1 2026 in Review

Walleye Capital increased its Wave Life Sciences (WVE) stake by 30% in Q1 2026, buying an estimated $1.49M and bringing the position to 493,512 shares worth $3.58M. The position accounts for 0.01% of the portfolio, ranked #1024.

Walleye Capital first reported a position in WVE in Q3 2020 and has held it in 15 quarters since. The position peaked at $6.52M in Q4 2024. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Walleye Capital held 493,512 shares of Wave Life Sciences worth $3.58M as of Q1 2026.
  • Walleye Capital bought 114,689 Wave Life Sciences shares in Q1 2026, an estimated $1.49M.
  • Wave Life Sciences made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1024 holding.
  • Walleye Capital first reported a position in Wave Life Sciences in Q3 2020 and has held it in 15 quarters since.
  • Walleye Capital's Wave Life Sciences position peaked at $6.52M in Q4 2024.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.